{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T23:07:59Z","timestamp":1779059279840,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Mol and Cell Biol"],"DOI":"10.1186\/s12860-026-00586-8","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T07:37:15Z","timestamp":1775461035000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chemoradiotherapy-induced Th17\/IL-17 signaling correlates with therapeutic tolerance and early recurrence in cervical carcinoma"],"prefix":"10.1186","volume":"27","author":[{"given":"Fanglei","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"issue":"1","key":"586_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1136\/ijgc-2018-000032","volume":"29","author":"XP Chao","year":"2019","unstructured":"Chao XP, Sun TT, Wang S, Fan QB, Shi HH, Zhu L, Lang JH. Correlation between the diversity of vaginal microbiota and the risk of high-risk human papillomavirus infection. Int J Gynecol Cancer. 2019;29(1):28\u201334.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"586_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.21147\/j.issn.1000-9604.2018.02.04","volume":"30","author":"K Serkies","year":"2018","unstructured":"Serkies K, Jassem J. Systemic therapy for cervical carcinoma\u2014current status. Chin J Cancer Res. 2018;30(2):209\u201321.","journal-title":"Chin J Cancer Res"},{"issue":"3","key":"586_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3747\/co.v17i3.514","volume":"17","author":"L Elit","year":"2010","unstructured":"Elit L, Fyles AW, Oliver TK, Devries-Aboud MC, Fung-Kee-Fung M; members of the Gynecology Cancer Disease Site Group of Cancer Care Ontario\u2019s Program in Evidence-Based Care. Follow-up for women after treatment for cervical cancer. Curr Oncol. 2010;17(3):65\u20139.","journal-title":"Curr Oncol"},{"issue":"2","key":"586_CR4","doi-asserted-by":"publisher","first-page":"e1267095","DOI":"10.1080\/2162402X.2016.1267095","volume":"6","author":"H van Meir","year":"2016","unstructured":"van Meir H, Nout RA, Welters MJ, Loof NM, de Kam ML, van Ham JJ, Samuels S, Kenter GG, Cohen AF, Melief CJ, Burggraaf J, van Poelgeest MI, van der Burg SH. Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients. Oncoimmunology. 2016;6(2):e1267095.","journal-title":"Oncoimmunology"},{"issue":"5","key":"586_CR5","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.ijrobp.2015.08.034","volume":"93","author":"X Zheng","year":"2015","unstructured":"Zheng X, Guo Y, Wang L, Zhang H, Wang S, Wang L, An L, Zhou X, Li X, Yao C. Recovery profiles of T-cell subsets following low-dose total body irradiation and improvement with cinnamon. Int J Radiat Oncol Biol Phys. 2015;93(5):1118\u201326.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"23","key":"586_CR6","doi-asserted-by":"publisher","first-page":"6585","DOI":"10.1158\/1078-0432.CCR-13-0900","volume":"19","author":"PJ Schuler","year":"2013","unstructured":"Schuler PJ, Harasymczuk M, Schilling B, Saze Z, Strauss L, Lang S, Johnson JT, Whiteside TL. Effects of adjuvant chemoradiotherapy on the frequency and function of regulatory T cells in patients with head and neck cancer. Clin Cancer Res. 2013;19(23):6585\u201396.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"586_CR7","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1002\/ijc.28549","volume":"134","author":"J Pahne-Zeppenfeld","year":"2014","unstructured":"Pahne-Zeppenfeld J, Schr\u00f6er N, Walch-R\u00fcckheim B, Oldak M, Gorter A, Hegde S, Smola S. Cervical cancer cell-derived interleukin-6 impairs CCR7-dependent migration of MMP-9-expressing dendritic cells. Int J Cancer. 2014;134(9):2061\u201373.","journal-title":"Int J Cancer"},{"key":"586_CR8","doi-asserted-by":"publisher","unstructured":"Sharma A, Rajappa M, Satyam A, Sharma M. Cytokines (TH1 and TH2) in patients with advanced cervical cancer undergoing neoadjuvant chemoradiation: correlation with treatment response. Int J Gynecol Cancer. 2009;19(7):1269-75. https:\/\/doi.org\/10.1111\/IGC.0b013e3181a8efcc. PMID: 19820390.","DOI":"10.1111\/IGC.0b013e3181a8efcc"},{"issue":"10","key":"586_CR9","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1136\/jcp.2004.025072","volume":"58","author":"AG Bais","year":"2005","unstructured":"Bais AG, Beckmann I, Lindemans J, Ewing PC, Meijer CJ, Snijders PJ, Helmerhorst TJ. A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions. J Clin Pathol. 2005;58(10):1096\u2013100. https:\/\/doi.org\/10.1136\/jcp.2004.025072. PMID: 16189158; PMCID: PMC1770745.","journal-title":"J Clin Pathol"},{"issue":"1","key":"586_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1158\/0008-5472.CAN-10-2193","volume":"71","author":"N Schr\u00f6er","year":"2011","unstructured":"Schr\u00f6er N, Pahne J, Walch B, Wickenhauser C, Smola S. Molecular pathobiology of human cervical high-grade lesions: paracrine STAT3 activation in tumor-instructed myeloid cells drives local MMP-9 expression. Cancer Res. 2011;71(1):87\u201397.","journal-title":"Cancer Res"},{"issue":"9","key":"586_CR11","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/v9090254","volume":"9","author":"S Smola","year":"2017","unstructured":"Smola S. Immunopathogenesis of HPV-associated cancers and prospects for immunotherapy. Viruses. 2017;9(9):254.","journal-title":"Viruses"},{"issue":"9","key":"586_CR12","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/nm.3291","volume":"19","author":"AS Chung","year":"2013","unstructured":"Chung AS, Wu X, Zhuang G, Ngu H, Kasman I, Zhang J, Vernes JM, Jiang Z, Meng YG, Peale FV. Ouyang W and Ferrara N. An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy. Nat Med. 2013;19(9):1114\u201323.","journal-title":"Nat Med"},{"issue":"1","key":"586_CR13","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41467-021-20893-2","volume":"12","author":"A Rodriguez-Garcia","year":"2021","unstructured":"Rodriguez-Garcia A, Lynn RC, Poussin M, Eiva MA, Shaw LC, O\u2019Connor RS, Minutolo NG, Casado-Medrano V, Lopez G, Matsuyama T, Powell DJ Jr. CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy. Nat Commun. 2021;12(1):877.","journal-title":"Nat Commun"},{"issue":"2","key":"586_CR14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/cam4.1279","volume":"7","author":"J Xue","year":"2018","unstructured":"Xue J, Wang Y, Chen C, Zhu X, Zhu H, Hu Y. Effects of Th17 cells and IL-17 in the progression of cervical carcinogenesis with high-risk human papillomavirus infection. Cancer Med. 2018;7(2):297\u2013306.","journal-title":"Cancer Med"},{"issue":"1","key":"586_CR15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12905-020-00972-0","volume":"20","author":"W Lin","year":"2020","unstructured":"Lin W, Zhang HL, Niu ZY, Wang Z, Kong Y, Yang XS, Yuan F. The disease stage-associated imbalance of Th1\/Th2 and Th17\/Treg in uterine cervical cancer patients and their recovery with the reduction of tumor burden. BMC Womens Health. 2020;20(1):126.","journal-title":"BMC Womens Health"},{"issue":"9","key":"586_CR16","first-page":"3604","volume":"12","author":"W Lin","year":"2019","unstructured":"Lin W, Niu Z, Zhang H, Kong Y, Wang Z, Yang X, Yuan F. Imbalance of Th1\/Th2 and Th17\/Treg during the development of uterine cervical cancer. Int J Clin Exp Pathol. 2019;12(9):3604\u201312.","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"586_CR17","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.4049\/jimmunol.167.5.2972","volume":"167","author":"BC Sheu","year":"2001","unstructured":"Sheu BC, Lin RH, Lien HC, Ho HN, Hsu SM, Huang SC. Predominant Th2\/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer. J Immunol. 2001;167(5):2972\u20138.","journal-title":"J Immunol"},{"issue":"9","key":"586_CR18","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/modpathol.2010.109","volume":"23","author":"IT \u00d8vestad","year":"2010","unstructured":"\u00d8vestad IT, Gudlaugsson E, Skaland I, Malpica A, Kruse AJ, Janssen EA, Baak JP. Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression. Mod Pathol. 2010;23(9):1231\u201340.","journal-title":"Mod Pathol"},{"issue":"22","key":"586_CR19","doi-asserted-by":"publisher","first-page":"6915","DOI":"10.1158\/0008-5472.CAN-11-1156","volume":"71","author":"WL Byrne","year":"2011","unstructured":"Byrne WL, Mills KH, Lederer JA, O\u2019Sullivan GC. Targeting regulatory T cells in cancer. Cancer Res. 2011;71(22):6915\u201320.","journal-title":"Cancer Res"},{"issue":"9","key":"586_CR20","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.4049\/jimmunol.1001323","volume":"185","author":"BH Nelson","year":"2010","unstructured":"Nelson BH. CD20\u2009+\u2009B cells: the other tumor-infiltrating lymphocytes. J Immunol. 2010;185(9):4977\u201382.","journal-title":"J Immunol"},{"key":"586_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev.immunol.19.1.275","volume":"19","author":"JV Ravetch","year":"2001","unstructured":"Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol. 2001;19:275\u201390.","journal-title":"Annu Rev Immunol"},{"key":"586_CR22","unstructured":"Soongsathitanon J, Homjan T, Pongcharoen S, et al. Characteristic features of in vitro differentiation of human na\u00efve CD4\u2009+\u2009T cells to iTreg and Th17 cells. Heliyon. 2024."},{"issue":"5","key":"586_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1159\/000515144","volume":"182","author":"NL Bertschi","year":"2021","unstructured":"Bertschi NL, Bazzini C, Schlapbach C. The concept of pathogenic TH2 cells: Collegium Internationale Allergologicum update 2021. Int Arch Allergy Immunol. 2021;182(5):365\u201380.","journal-title":"Int Arch Allergy Immunol"},{"issue":"12","key":"586_CR24","doi-asserted-by":"publisher","first-page":"909","DOI":"10.4049\/immunohorizons.2100017","volume":"5","author":"S Park","year":"2021","unstructured":"Park S, Anderson NL, Canaria DA, Olson MR. Granzyme-producing CD4 T cells in cancer and autoimmune disease. Immunohorizons. 2021;5(12):909\u201317.","journal-title":"Immunohorizons"},{"key":"586_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.pvr.2017.12.006","volume":"5","author":"A Chabeda","year":"2018","unstructured":"Chabeda A, Yanez RJR, Lamprecht R, Meyers AE, Rybicki EP, Hitzeroth II. Therapeutic vaccines for high-risk HPV-associated diseases. Papillomavirus Res. 2018;5:46\u201358.","journal-title":"Papillomavirus Res"},{"key":"586_CR26","doi-asserted-by":"publisher","first-page":"642842","DOI":"10.3389\/fimmu.2021.642842","volume":"12","author":"U de Avila-Ponce","year":"2021","unstructured":"de Avila-Ponce U, V\u00e1zquez-Jim\u00e9nez A, Matadamas-Guzman M, Pelayo R, Resendis-Antonio O. Transcriptional and microenvironmental landscape of macrophage transition in cancer: a boolean analysis. Front Immunol. 2021;12:642842.","journal-title":"Front Immunol"},{"key":"586_CR27","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.3389\/fimmu.2018.02359","volume":"9","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Lu W, Liang CL, Chen Y, Liu H, Qiu F, Dai Z. Chimeric antigen receptor (CAR) Treg: a promising approach to inducing immunological tolerance. Front Immunol. 2018;9:2359.","journal-title":"Front Immunol"},{"issue":"1","key":"586_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41423-019-0306-1","volume":"17","author":"K Nakamura","year":"2020","unstructured":"Nakamura K, Smyth MJ. Myeloid immunosuppression and immune checkpoints in the tumor microenvironment. Cell Mol Immunol. 2020;17(1):1\u201312.","journal-title":"Cell Mol Immunol"},{"issue":"13","key":"586_CR29","doi-asserted-by":"publisher","first-page":"108571","DOI":"10.1016\/j.celrep.2020.108571","volume":"33","author":"T Kwak","year":"2020","unstructured":"Kwak T, Wang F, Deng H, Condamine T, Kumar V, Perego M, Kossenkov A, Montaner LJ, Xu X, Xu W, Zheng C, Schuchter LM, Amaravadi RK, Mitchell TC, Karakousis GC, Mulligan C, Nam B, Masters G, Hockstein N, Bennett J, Nefedova Y, Gabrilovich DI. Distinct populations of immune-suppressive macrophages differentiate from monocytic myeloid-derived suppressor cells in cancer. Cell Rep. 2020;33(13):108571.","journal-title":"Cell Rep"},{"issue":"6","key":"586_CR30","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/cyto.a.23724","volume":"95","author":"CM Mousset","year":"2019","unstructured":"Mousset CM, Hobo W, Woestenenk R, Preijers F, Dolstra H, van der Waart AB. Comprehensive phenotyping of T cells using flow cytometry. Cytometry A. 2019;95(6):647\u201354.","journal-title":"Cytometry A"},{"issue":"6","key":"586_CR31","doi-asserted-by":"publisher","first-page":"822","DOI":"10.4161\/onci.20491","volume":"1","author":"PD Guirnalda","year":"2012","unstructured":"Guirnalda PD, Paterson Y. Vaccination with immunotherapeutic Listeria monocytogenes induces IL-17(+) \u03b3\u03b4 T cells in a murine model for HPV associated cancer. Oncoimmunology. 2012;1(6):822\u20138.","journal-title":"Oncoimmunology"},{"issue":"27","key":"586_CR32","doi-asserted-by":"publisher","first-page":"10425","DOI":"10.1074\/jbc.AC118.001720","volume":"293","author":"X Wu","year":"2018","unstructured":"Wu X, Gowda NM, Kawasawa YI, Gowda DC. A malaria protein factor induces IL-4 production by dendritic cells via PI3K-Akt-NF-\u03baB signaling independent of MyD88\/TRIF and promotes Th2 response. J Biol Chem. 2018;293(27):10425\u201334.","journal-title":"J Biol Chem"},{"issue":"13","key":"586_CR33","doi-asserted-by":"publisher","first-page":"2003376","DOI":"10.1002\/advs.202003376","volume":"8","author":"L Jia","year":"2021","unstructured":"Jia L, Wang Y, Wang CY. circFAT1 promotes cancer stemness and immune evasion by promoting STAT3 activation. Adv Sci (Weinh). 2021;8(13):2003376.","journal-title":"Adv Sci (Weinh)"},{"issue":"8","key":"586_CR34","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1002\/anie.202013366","volume":"60","author":"Y Long","year":"2021","unstructured":"Long Y, Cao B, Xiong X, Chan ASC, Sun RW, Zou T. Bioorthogonal activation of dual catalytic and anti-cancer activities of organogold (I) complexes in living systems. Angew Chem Int Ed Engl. 2021;60(8):4133\u201341.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"11","key":"586_CR35","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1007\/s00262-020-02612-w","volume":"69","author":"CM Mousset","year":"2020","unstructured":"Mousset CM, Hobo W, de Ligt A, Baardman S, Schaap NPM, Jansen JH, van der Waart AB, Dolstra H. Cell composition and expansion strategy can reduce the beneficial effect of AKT-inhibition on functionality of CD8\u2009+\u2009T cells. Cancer Immunol Immunother. 2020;69(11):2259\u201373.","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"586_CR36","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1159\/000509095","volume":"64","author":"V Pergialiotis","year":"2020","unstructured":"Pergialiotis V, Nikolaou C, Haidopoulos D, Frountzas M, Thomakos N, Bellos I, Papapanagiotou A, Rodolakis A. PIK3CA mutations and their impact on survival outcomes of patients with cervical cancer: a systematic review. Acta Cytol. 2020;64(6):547\u201355.","journal-title":"Acta Cytol"},{"issue":"4","key":"586_CR37","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/19336918.2015.1016686","volume":"9","author":"W Xu","year":"2015","unstructured":"Xu W, Yang Z, Lu N. A new role for the PI3K\/Akt signaling pathway in the epithelial-mesenchymal transition. Cell Adh Migr. 2015;9(4):317\u201324.","journal-title":"Cell Adh Migr"},{"key":"586_CR38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ceb.2017.02.007","volume":"45","author":"EC Lien","year":"2017","unstructured":"Lien EC, Dibble CC, Toker A. PI3K signaling in cancer: beyond AKT. Curr Opin Cell Biol. 2017;45:62\u201371.","journal-title":"Curr Opin Cell Biol"}],"container-title":["BMC Molecular and Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12860-026-00586-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12860-026-00586-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12860-026-00586-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T23:00:58Z","timestamp":1779058858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12860-026-00586-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["586"],"URL":"https:\/\/doi.org\/10.1186\/s12860-026-00586-8","relation":{},"ISSN":["2661-8850"],"issn-type":[{"value":"2661-8850","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study exclusively utilized commercially available, established human cervical carcinoma cell lines. No primary human tissues or patient-derived samples were collected, and no human subjects were directly involved. Therefore, ethical approval and informed consent were not required in accordance with institutional and national guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}